365 related articles for article (PubMed ID: 12917806)
41. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
Wells J
Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
[TBL] [Abstract][Full Text] [Related]
42. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
[TBL] [Abstract][Full Text] [Related]
43. Secretion of biologically active porcine interleukin-2 by Lactococcus lactis.
Avall-Jääskeläinen S; Palva A
Vet Microbiol; 2006 Jun; 115(1-3):278-83. PubMed ID: 16549279
[TBL] [Abstract][Full Text] [Related]
44. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination.
Wang K; Huang L; Kong J; Zhang X
J Virol Methods; 2008 Jun; 150(1-2):1-6. PubMed ID: 18406475
[TBL] [Abstract][Full Text] [Related]
45. Lactococcus lactis as a vehicle for the heterologous expression of fungal ribotoxin variants with reduced IgE-binding affinity.
Alvarez-García E; Alegre-Cebollada J; Batanero E; Monedero V; Pérez-Martínez G; García-Fernández R; Gavilanes JG; del Pozo AM
J Biotechnol; 2008 Mar; 134(1-2):1-8. PubMed ID: 18289711
[TBL] [Abstract][Full Text] [Related]
46. [Food-grade gene expression systems for lactic acid bacteria].
Zhang ZZ; Chen XZ; Jia SF; Chen ML; Huan LD
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):516-20. PubMed ID: 12385256
[TBL] [Abstract][Full Text] [Related]
47. Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis.
Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Gruss A; Rodriguez-Padilla C; Saucedo-Cardenas O; Langella P; Montes de Oca-Luna R
Biotechnol Prog; 2003; 19(3):1101-4. PubMed ID: 12790689
[TBL] [Abstract][Full Text] [Related]
48. [Construction of food-grade inducible expression system in Lactococcus lactis and expression of fusion OprF/H from Pseudomonas aeruginosa].
Xu B; Cao YS; Chen Y; Guo XH
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):604-9. PubMed ID: 17944358
[TBL] [Abstract][Full Text] [Related]
49. A review on Lactococcus lactis: from food to factory.
Song AA; In LLA; Lim SHE; Rahim RA
Microb Cell Fact; 2017 Apr; 16(1):55. PubMed ID: 28376880
[TBL] [Abstract][Full Text] [Related]
50. [The NICE system as a tool for protein expression in Lactococcus lactis].
Olejnik-Schmidt A; Gronowalska A; Schmidt M
Postepy Biochem; 2013; 59(3):322-6. PubMed ID: 24364215
[TBL] [Abstract][Full Text] [Related]
51. [Construction of recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis spike glycoprotein and analysis of immunogenicity].
Tang LJ; Ou D; Ge JW; Xu YG; Li YJ; Shi D; Xia CL; Yu Y
Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):340-4. PubMed ID: 17552246
[TBL] [Abstract][Full Text] [Related]
52. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
Sim AC; Lin W; Tan GK; Sim MS; Chow VT; Alonso S
Vaccine; 2008 Feb; 26(9):1145-54. PubMed ID: 18243432
[TBL] [Abstract][Full Text] [Related]
53. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
Frossard CP; Steidler L; Eigenmann PA
J Allergy Clin Immunol; 2007 Apr; 119(4):952-9. PubMed ID: 17316776
[TBL] [Abstract][Full Text] [Related]
54. In situ delivery of therapeutic cytokines by genetically engineered Lactococcus lactis.
Steidler L
Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(3b):551, 553-6. PubMed ID: 15954652
[No Abstract] [Full Text] [Related]
55. Lactic acid bacteria as oral delivery systems for biomolecules.
Berlec A; Ravnikar M; Strukelj B
Pharmazie; 2012 Nov; 67(11):891-8. PubMed ID: 23210237
[TBL] [Abstract][Full Text] [Related]
56. Secretory expression of K88 (F4) fimbrial adhesin FaeG by recombinant Lactococcus lactis for oral vaccination and its protective immune response in mice.
Hu CX; Xu ZR; Li WF; Niu D; Lu P; Fu LL
Biotechnol Lett; 2009 Jul; 31(7):991-7. PubMed ID: 19277476
[TBL] [Abstract][Full Text] [Related]
57. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
58. Secretion of human interferon-beta 1b by recombinant Lactococcus lactis.
Zhuang Z; Wu ZG; Chen M; Wang PG
Biotechnol Lett; 2008 Oct; 30(10):1819-23. PubMed ID: 18575814
[TBL] [Abstract][Full Text] [Related]
59. [Construction of a food-grade secretion expression vector and use it for reporter protein expression in Lactococcus lactis].
Sun Q; Xiong Y; Ye C; Xu J
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):293-8. PubMed ID: 18479053
[TBL] [Abstract][Full Text] [Related]
60. Production of human growth hormone by Lactococcus lactis.
Margolles A; Moreno JA; Ruiz L; Marelli B; Magni C; de Los Reyes-Gavilán CG; Ruas-Madiedo P
J Biosci Bioeng; 2010 Apr; 109(4):322-4. PubMed ID: 20226370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
